skip to primary navigationskip to content

GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

last modified Sep 29, 2016 10:46 AM
The largest genetics laboratory in the NHS brings to the platform their solid tumour sequencing, enabling clinicians to give an individual approach to their patients, tailored to their tumour’s genetic makeup.
GeneAdviser partners with Birmingham Women’s Hospital to make personalised medicine more accessible

 GeneAdvisor's CEO Jelena Aleksic (left) and CTO Robert Stojnic (right)

GeneAdviser is bringing the expertise of Birmingham Women’s Hospital to their ordering platform, where healthcare professionals can now order tests for genetic sequencing of tumour samples, screening for those changes in the tumour that may require clinical action.

Each tumour has a different genetic makeup, which makes it react to therapies very differently. By analysing and monitoring the presence of genetic sequences in a tumour, patients can be prescribed more targeted treatment and screening.

Dr Jelena Aleksic, GeneAdviser’s CEO, commented: “Birmingham Women’s Hospital combines outstanding and comprehensive genetics research and clinical expertise, making it an internationally renowned clinical laboratory. We are delighted to make their excellent genetic testing more accessible to doctors worldwide, helping them provide better care for their patients.”

Professor Michael Griffiths, the Birmingham Women’s Hospital Genetics Laboratory Director, added: "We are excited to join forces with GeneAdviser to facilitate worldwide access to our genetic test portfolio.  As the largest NHS genetics laboratory we already work closely with clinicians across the UK and internationally, and GeneAdviser will allow them to easily order the genetic  tests they need for their patients, whilst streamlining administrative processes for our staff."

Their partnership also expands beyond solid tumour sequencing, bringing forward a selection of high quality genetic tests in oncology and other medical specialties. Other tests from Birmingham Women’s Hospital include their Lucina NIPT (non invasive prenatal testing), a highly accurate genetic prenatal testing that screens for trisomies such as Down syndrome using a single maternal blood sample.

RSS Feed Latest news

Conferences: Get the Most Out of Your Trade Show Experience

Jul 31, 2019

Exhibiting at a conference can be an extremely effective way to meet with potential customers and generate leads, as well as build your start-ups brand presence and create a buzz. But they can be expensive and if not planned well, can waste your small company’s limited resources. Advanced and strategic planning is key to making the most of the experience. So we asked two of our founders, Vaughan Wittorff, Co-Founder & Chief Commercial Officer at PetaGene, and John Pettigrew, Founder and CEO of We Are Futureproofs, for their thoughts on how to approach an exhibition.

Celebrating World Environment Day - Polysolar’s Contribution to Saving our Planet

Jun 05, 2019

ideaSpace exists to support founders with scalable innovative ideas which could potentially address global threats like climate change. To celebrate World Environment Day we spoke to Hamish Watson, founder of ideaSpace alumni company Polysolar – a leader in the provision of solar PV glass for energy generation in buildings. He took us through Polysolar’s story, from product inception to where it is today, and shared his thoughts on the secret to the company’s success, the challenges that have shaped its growth, and some advice on crowdfunding.

View all news